Cardinal Health (CAH) Stock Forecast & Price Target

$110.52

+0.73 (+0.66%)

(As of 09/30/2024 ET)

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
1

Hold
4

Buy
7

Based on 12 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 1 has given a sell rating, 4 have given a hold rating, and 7 have given a buy rating for CAH.

Consensus Price Target

$119.36
8.00% Upside

According to the 12 analysts' twelve-month price targets for Cardinal Health, the average price target is $119.36. The highest price target for CAH is $137.00, while the lowest price target for CAH is $101.00. The average price target represents a forecasted upside of 8.00% from the current price of $110.52.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$119.36	$118.45	$109.67	$94.69
Forecasted Upside	8.00% Upside	5.09% Upside	14.59% Upside	9.62% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure (Ad)

The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.

Click here now to learn how you can position yourself for potentially massive gains.

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.78	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	8.00% Upside	823.01% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/11/2024	Argus 3 of 5 stars		Boost Target	Buy ➝ Buy	$115.00 ➝ $125.00	+10.34%
8/21/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Neutral ➝ Neutral	$111.00 ➝ $123.00	+12.23%
8/16/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Boost Target	Hold ➝ Hold	$115.00 ➝ $119.00	+8.98%
8/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$114.00 ➝ $119.00	+10.19%
8/15/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underweight ➝ Underweight	$95.00 ➝ $101.00	-6.48%
8/15/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$120.00 ➝ $125.00	+15.74%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
8/15/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $137.00	+28.81%
8/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$105.00 ➝ $115.00	+8.12%
7/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $107.00	+11.98%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+15.64%
1/3/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$117.00	+14.01%
8/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$88.00 ➝ $90.00	-0.56%
8/16/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$94.00 ➝ $96.00	+6.04%
7/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$91.00 ➝ $99.00	+6.29%
6/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+15.82%
11/4/2022	Bank Of America (Bofa) Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$64.00 ➝ $80.00	+2.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:34 AM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

Cardinal Health, Inc. has a market capitalization of $27.59 billion, indicating its size and stability in the market.
The company recently increased its quarterly dividend, which can be attractive to income-seeking investors.
Insider selling activity, while notable, can sometimes indicate a belief in the company's future performance.
Cardinal Health's revenue growth of 12.1% compared to the same quarter last year demonstrates positive momentum.
The company's P/E ratio of 50.38 may suggest growth potential, albeit at a higher valuation.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

Cardinal Health, Inc. has a negative return on equity of 54.85%, indicating potential financial inefficiencies.
The company's dividend payout ratio of 89.78% may raise concerns about sustainability and future growth.
Recent insider selling activity, including a significant sale by an insider, could raise questions about internal confidence.
Cardinal Health's beta of 0.60 suggests lower volatility compared to the market, which may limit potential returns.
Investors should carefully consider the company's price-to-earnings-growth ratio of 1.55 to assess its valuation relative to expected growth.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $119.36, with a high forecast of $137.00 and a low forecast of $101.00.
: 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CAH shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 8.00% based on their 12-month stock forecasts.
: Cardinal Health has been rated by research analysts at Argus, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Cardinal Health less than other "medical" companies. The consensus rating score for Cardinal Health is 2.50 while the average consensus rating score for "medical" companies is 2.78. Learn more on how CAH compares to other companies.